Long-term viability of coronary artery smooth muscle cells on poly(l-lactide-co-ε-caprolactone) nanofibrous scaffold indicates its potential for blood vessel tissue engineering

Biodegradable polymer nanofibres have been extensively studied as cell culture scaffolds in tissue engineering. However, long-term in vitro studies of cell–nanofibre interactions were rarely reported and successful organ regeneration using tissue engineering techniques may take months (e.g. blood vessel tissue engineering). Understanding the long-term interaction between cells and nanofibrous scaffolds (NFS) is crucial in material selection, design and processing of the tissue engineering scaffolds. In this study, poly(l-lactide-co-ε-caprolactone) [P(LLA-CL)] (70 : 30) copolymer NFS were produced by electrospinning. Porcine coronary artery smooth muscle cells (PCASMCs) were seeded and cultured on the scaffold to evaluate cell–nanofibre interactions for up to 105 days. A favourable interaction between this scaffold and PCASMCs was demonstrated by cell viability assay, scanning electron microscopy, histological staining and extracellular matrix (ECM) secretion. Degradation behaviours of the scaffolds with or without PCASMC culture were determined by mechanical testing and gel permeation chromatography (GPC). The results showed that the PCASMCs attached and proliferated well on the P(LLA-CL) NFS. Large amount of ECM protein secretion was observed after 50 days of culture. Multilayers of aligned oriented PCASMCs were formed on the scaffold after two months of in vitro culture. In the degradation study, the PCASMCs were not shown to significantly increase the degradation rate of the scaffolds for up to 105 days of culture. The in vitro degradation time of the scaffold could be as long as eight months by extrapolating the results from GPC. These observations further supported the potential use of the P(LLA-CL) nanofibre in blood vessel tissue engineering.

[1]  E. Raines,et al.  The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease , 2000, International journal of experimental pathology.

[2]  Benjamin Chu,et al.  Antithrombogenic property of bone marrow mesenchymal stem cells in nanofibrous vascular grafts , 2007, Proceedings of the National Academy of Sciences.

[3]  F. Rosso,et al.  From Cell–ECM interactions to tissue engineering , 2004, Journal of cellular physiology.

[4]  Julian H. George,et al.  Exploring and Engineering the Cell Surface Interface , 2005, Science.

[5]  B. Říhová,et al.  Biocompatibility of biomaterials: hemocompatibility, immunocompatiblity and biocompatibility of solid polymeric materials and soluble targetable polymeric carriers , 1996 .

[6]  M. van der Elst,et al.  Bone tissue response to biodegradable polymers used for intra medullary fracture fixation: a long-term in vivo study in sheep femora. , 1999, Biomaterials.

[7]  Sang Bong Lee,et al.  Tissue-engineered vascular grafts composed of marine collagen and PLGA fibers using pulsatile perfusion bioreactors. , 2007, Biomaterials.

[8]  Gary E. Wnek,et al.  TAILORING TISSUE ENGINEERING SCAFFOLDS USING ELECTROSTATIC PROCESSING TECHNIQUES: A STUDY OF POLY(GLYCOLIC ACID) ELECTROSPINNING , 2001 .

[9]  E Bell,et al.  A blood vessel model constructed from collagen and cultured vascular cells. , 1986, Science.

[10]  Cato T Laurencin,et al.  Electrospun nanofibrous structure: a novel scaffold for tissue engineering. , 2002, Journal of biomedical materials research.

[11]  B. Johansson,et al.  Production of extracellular matrix components in tissue-engineered blood vessels. , 2006, Tissue engineering.

[12]  R Langer,et al.  Morphologic and mechanical characteristics of engineered bovine arteries. , 2001, Journal of vascular surgery.

[13]  M. Kotaki,et al.  Aligned biodegradable nanofibrous structure: a potential scaffold for blood vessel engineering. , 2004, Biomaterials.

[14]  M. Davies,et al.  Pathobiology of intimal hyperplasia , 1994, The British journal of surgery.

[15]  A. Newby,et al.  Molecular mechanisms in intimal hyperplasia , 2000, The Journal of pathology.

[16]  F A Auger,et al.  A completely biological tissue‐engineered human blood vessel , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  D. Reneker,et al.  Nanometre diameter fibres of polymer, produced by electrospinning , 1996 .

[18]  E. Chaikof,et al.  High-resolution analysis of engineered type I collagen nanofibers by electron microscopy. , 2001, Scanning.

[19]  Kwangsok Kim,et al.  Control of degradation rate and hydrophilicity in electrospun non-woven poly(D,L-lactide) nanofiber scaffolds for biomedical applications. , 2003, Biomaterials.

[20]  Minna Hakkarainen,et al.  Aliphatic polyesters : Abiotic and biotic degradation and degradation products , 2002 .

[21]  J D Stitzel,et al.  Arterial Smooth Muscle Cell Proliferation on a Novel Biomimicking, Biodegradable Vascular Graft Scaffold , 2001, Journal of biomaterials applications.

[22]  T. M. Stich.  Determination of protein covalently bound to agarose supports using bicinchoninic acid. , 1990, Analytical biochemistry.

[23]  J. Campbell,et al.  Novel vascular graft grown within recipient's own peritoneal cavity. , 1999, Circulation research.

[24]  Xuesi Chen,et al.  Enzymatic degradation of poly(L-lactide) and poly(epsilon-caprolactone) electrospun fibers. , 2004, Macromolecular bioscience.

[25]  J. Vacanti,et al.  A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering. , 2003, Biomaterials.

[26]  Eric J. Topol,et al.  Pan Vascular Medicine : integrated clinical management , 2002 .

[27]  Julie H. Campbell,et al.  Dog peritoneal and pleural cavities as bioreactors to grow autologous vascular grafts. , 2004, Journal of vascular surgery.

[28]  Seeram Ramakrishna,et al.  Electrospun nanofiber fabrication as synthetic extracellular matrix and its potential for vascular tissue engineering. , 2004, Tissue engineering.

[29]  Joseph P Vacanti,et al.  Toward a new blood vessel , 2002, Vascular medicine.

[30]  L. Niklason,et al.  Effects of polyglycolic acid on porcine smooth muscle cell growth and differentiation. , 2003, Journal of biomedical materials research. Part A.

[31]  N. L'Heureux,et al.  Human tissue-engineered blood vessels for adult arterial revascularization , 2007, Nature Medicine.

[32]  É. Allaire,et al.  Endothelial cell injury in cardiovascular surgery: the intimal hyperplastic response. , 1997, The Annals of thoracic surgery.

[33]  P. Zilla,et al.  Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: a 9-year experience. , 1999, Surgery.

[34]  M. Kotaki,et al.  Electrospun P(LLA-CL) nanofiber: a biomimetic extracellular matrix for smooth muscle cell and endothelial cell proliferation. , 2004, Biomaterials.

[35]  W. Park,et al.  In vitro degradation behavior of electrospun polyglycolide, polylactide, and poly(lactide‐co‐glycolide) , 2005 .

[36]  Jan Feijen,et al.  Physical characterization of vascular grafts cultured in a bioreactor. , 2006, Biomaterials.

[37]  P. Hagen,et al.  Remodeling of an acellular collagen graft into a physiologically responsive neovessel , 1999, Nature Biotechnology.

[38]  Nobuhiko Yui,et al.  Electrospun PLGA nanofiber scaffolds for articular cartilage reconstruction: mechanical stability, degradation and cellular responses under mechanical stimulation in vitro , 2006, Journal of biomaterials science. Polymer edition.

[39]  R Langer,et al.  Functional arteries grown in vitro. , 1999, Science.

[40]  Benjamin Chu,et al.  Structure and morphology changes during in vitro degradation of electrospun poly(glycolide-co-lactide) nanofiber membrane. , 2003, Biomacromolecules.

[41]  J. Lipscombe,et al.  Transplantation of human endothelial cell monolayer on artificial vascular prosthesis: the effect of growth-support surface chemistry, cell seeding density, ECM protein coating, and growth factors. , 1996, Artificial cells, blood substitutes, and immobilization biotechnology.

[42]  Narutoshi Hibino,et al.  The tissue-engineered vascular graft using bone marrow without culture. , 2005, The Journal of thoracic and cardiovascular surgery.

[43]  A. Ratcliffe.  Tissue engineering of vascular grafts. , 2000, Matrix biology : journal of the International Society for Matrix Biology.

[44]  Jan Feijen,et al.  Biological characterisation of vascular grafts cultured in a bioreactor. , 2006, Biomaterials.

[45]  C. Shanahan,et al.  Vascular Extracellular Matrix , 2002 .

[46]  J. Deitzel,et al.  The effect of processing variables on the morphology of electrospun nanofibers and textiles , 2001 .

[47]  Ameet Bakhai,et al.  Cost-Effectiveness of Sirolimus-Eluting Stents for Treatment of Complex Coronary Stenoses: Results From the Sirolimus-Eluting Balloon Expandable Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions (SIRIUS) Trial , 2004, Circulation.

[48]  David G Simpson,et al.  Electrospinning of collagen nanofibers. , 2002, Biomacromolecules.